ifosfamide has been researched along with Acute Lymphoid Leukemia in 28 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In acute lymphoblastic leukemia (ALL) the bone marrow microenvironment provides growth and survival signals that may confer resistance to chemotherapy." | 2.80 | Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia. ( DiPersio, JF; Fletcher, TR; Hsu, YM; Link, DC; Schmidt, AP; Stock, W; Trinkaus, KM; Uy, GL; Westervelt, P, 2015) |
| "Therapy for group non-B patients (lymphoblastic lymphoma and pleomorphic T-cell lymphoma [PTCL]) consisted of a Berlin-Frankfurt-Münster (BFM) acute lymphoblastic leukemia protocol, including cranial irradiation for advanced stage." | 2.68 | Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. ( Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW, 1995) |
| "The ifosfamide was escalated in 20% increments to the maximum tolerated dosage in cohorts of three patients." | 2.67 | Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study. ( Bell, B; Bernstein, ML; Buchanan, GR; Devine, S; Dreyer, Z; Grier, H; Krischer, J; Kung, F; Land, V; Whitehead, VM, 1993) |
| "Etoposide has also been tested in a wide range of combination regimens, but for many of these combinations, relatively few patients are included, and some combinations have only been tested in patients who have undergone autologous transplants." | 2.48 | High-dose etoposide in allogeneic stem cell transplantation. ( Ahmed, AB; Bruserud, O; Hatfield, KJ; Kittang, AO; Reikvam, H; Sjo, M; Tvedt, TH, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (50.00) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Peng, T | 1 |
| Wang, Y | 1 |
| Gan, X | 1 |
| Zhang, L | 1 |
| Chang, WJ | 1 |
| Ko, YH | 1 |
| Kim, SJ | 1 |
| Kim, WS | 1 |
| Zubowska, M | 1 |
| Wyka, K | 1 |
| Fendler, W | 1 |
| Młynarski, W | 1 |
| Zalewska-Szewczyk, B | 1 |
| Uy, GL | 1 |
| Hsu, YM | 1 |
| Schmidt, AP | 1 |
| Stock, W | 1 |
| Fletcher, TR | 1 |
| Trinkaus, KM | 1 |
| Westervelt, P | 1 |
| DiPersio, JF | 1 |
| Link, DC | 1 |
| Griffin, TC | 1 |
| Weitzman, S | 1 |
| Weinstein, H | 1 |
| Chang, M | 1 |
| Cairo, M | 1 |
| Hutchison, R | 1 |
| Shiramizu, B | 1 |
| Wiley, J | 1 |
| Woods, D | 1 |
| Barnich, M | 1 |
| Gross, TG | 1 |
| Bruserud, O | 1 |
| Reikvam, H | 1 |
| Kittang, AO | 1 |
| Ahmed, AB | 1 |
| Tvedt, TH | 1 |
| Sjo, M | 1 |
| Hatfield, KJ | 1 |
| Styczyński, J | 2 |
| Wysocki, M | 2 |
| Debski, R | 1 |
| Balwierz, W | 1 |
| Rokicka-Milewska, R | 1 |
| Matysiak, M | 1 |
| Balcerska, A | 1 |
| Kowalczyk, J | 1 |
| Wachowiak, J | 1 |
| Sońta-Jakimczyk, D | 1 |
| Chybicka, A | 1 |
| Pocali, B | 1 |
| De Simone, M | 1 |
| Annunziata, M | 1 |
| Palmieri, S | 1 |
| D'Amico, MR | 1 |
| Copia, C | 1 |
| Viola, A | 1 |
| Mele, G | 1 |
| Schiavone, EM | 1 |
| Ferrara, F | 1 |
| Thomson, B | 1 |
| Park, JR | 1 |
| Felgenhauer, J | 1 |
| Meshinchi, S | 1 |
| Holcenberg, J | 1 |
| Geyer, JR | 1 |
| Avramis, V | 1 |
| Douglas, JG | 1 |
| Loken, MR | 1 |
| Hawkins, DS | 1 |
| Klumper, E | 1 |
| Pieters, R | 2 |
| Veerman, AJ | 2 |
| Huismans, DR | 2 |
| Loonen, AH | 1 |
| Hählen, K | 1 |
| Kaspers, GJ | 1 |
| van Wering, ER | 1 |
| Hartmann, R | 1 |
| Henze, G | 2 |
| Inhorn, RC | 1 |
| Aster, JC | 1 |
| Roach, SA | 1 |
| Slapak, CA | 1 |
| Soiffer, R | 1 |
| Tantravahi, R | 1 |
| Stone, RM | 1 |
| Crooks, GM | 1 |
| Sato, JK | 1 |
| Reiter, A | 2 |
| Schrappe, M | 2 |
| Parwaresch, R | 1 |
| Müller-Weihrich, S | 1 |
| Sauter, S | 1 |
| Sykora, KW | 1 |
| Ludwig, WD | 1 |
| Gadner, H | 1 |
| Riehm, H | 2 |
| Bernstein, ML | 2 |
| Whitehead, VM | 1 |
| Devine, S | 1 |
| Grier, H | 1 |
| Kung, F | 1 |
| Krischer, J | 1 |
| Dreyer, Z | 1 |
| Bell, B | 1 |
| Land, V | 1 |
| Buchanan, GR | 1 |
| Schiller, G | 1 |
| Lee, M | 1 |
| Territo, M | 1 |
| Gajewski, J | 1 |
| Nimer, S | 1 |
| Welte, K | 1 |
| Mempel, K | 1 |
| Pfetsch, M | 1 |
| Schwab, G | 1 |
| Soslow, RA | 1 |
| Davis, RE | 1 |
| Warnke, RA | 1 |
| Cleary, ML | 1 |
| Kamel, OW | 1 |
| Ducharme, MP | 1 |
| Granvil, CP | 1 |
| Gehrcke, B | 1 |
| Wainer, IW | 1 |
| Otero, JC | 1 |
| Solidoro, A | 1 |
| Casanova, L | 1 |
| Vallejos, C | 1 |
| Rodriguez, W | 1 |
| Yule, SM | 1 |
| Price, L | 1 |
| Pearson, AD | 1 |
| Boddy, AV | 1 |
| Schuurhuis, GJ | 1 |
| Lovett, BD | 1 |
| Lo Nigro, L | 1 |
| Rappaport, EF | 1 |
| Blair, IA | 1 |
| Osheroff, N | 1 |
| Zheng, N | 1 |
| Megonigal, MD | 1 |
| Williams, WR | 1 |
| Nowell, PC | 1 |
| Felix, CA | 1 |
| Lee, EJ | 1 |
| Petroni, GR | 1 |
| Schiffer, CA | 1 |
| Freter, CE | 1 |
| Johnson, JL | 1 |
| Barcos, M | 1 |
| Frizzera, G | 1 |
| Bloomfield, CD | 1 |
| Peterson, BA | 1 |
| Kingma, A | 1 |
| Van Dommelen, RI | 1 |
| Mooyaart, EL | 1 |
| Wilmink, JT | 1 |
| Deelman, BG | 1 |
| Kamps, WA | 1 |
| Naresh, KN | 1 |
| Banavali, SD | 1 |
| Bhatia, KG | 1 |
| Magrath, I | 1 |
| Soman, CS | 1 |
| Advani, SH | 1 |
| Herbrecht, R | 1 |
| Damonte, JC | 1 |
| Dufour, P | 1 |
| Maloisel, F | 1 |
| Liu, KL | 1 |
| Ortiz, S | 1 |
| Bergerat, JP | 1 |
| Oberling, F | 1 |
| Iwasaku-Fujimoto, M | 1 |
| Fujiwara, F | 1 |
| Todo, S | 1 |
| Morioka, Y | 1 |
| Imashuku, S | 1 |
| Freund, M | 1 |
| De Boben, M | 1 |
| Diedrich, H | 1 |
| Ganser, A | 1 |
| Heil, G | 1 |
| Heyll, A | 1 |
| Henke, M | 1 |
| Hiddemann, W | 1 |
| Knauf, U | 1 |
| Koch, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia[NCT01429610] | Phase 2 | 78 participants (Actual) | Interventional | 2011-11-30 | Active, not recruiting | ||
| Intensive Conditioning Regimen With Thiotepa Combined With Busulfan, Fludarabine and Cytarabine for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Myeloid Malignancies With Extramedullary Involvement[NCT06111612] | 50 participants (Anticipated) | Observational | 2024-01-01 | Not yet recruiting | |||
| Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193] | Phase 2 | 20 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA AND THE L-3 SUBTYPE OF ALL: A PILOT STUDY OF A MULTIDRUG REGIMEN[NCT00002494] | Phase 2 | 134 participants (Actual) | Interventional | 1992-05-31 | Completed | ||
| Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473] | Phase 2 | 100 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
High-dose etoposide in allogeneic stem cell transplantation.
Topics: Adenine Nucleotides; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chem | 2012 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1995 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
9 trials available for ifosfamide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Cell Activating Factor; Bone Marrow; | 2015 |
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2009 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone | 2004 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 1995 |
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantat | 1993 |
Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Leukoc | 1993 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1996 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid | 2001 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl | 1990 |
17 other studies available for ifosfamide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Expression and Clinical Significance of circRNA Changes in Stored Erythrocytes During Platelet Transfusion in Acute Lymphoblastic Leukemia.
Topics: Clinical Relevance; Etoposide; Humans; Ifosfamide; MicroRNAs; Platelet Transfusion; Precursor Cell L | 2023 |
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Human | 2014 |
Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment.
Topics: Adolescent; Antineoplastic Agents; beta 2-Microglobulin; Biomarkers; Carboplatin; Child; Child, Pres | 2013 |
In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Glucose; Humans; Ifosfamide; In Vitro | 2002 |
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Etop | 2004 |
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Ant | 1995 |
Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Eto | 1995 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati | 1996 |
Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.
Topics: Alkylation; Antineoplastic Agents, Alkylating; Child; Female; Gas Chromatography-Mass Spectrometry; | 1997 |
Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Clinical Trials, Phase I as Topic; Drug Combin | 1996 |
Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.
Topics: Adolescent; Antineoplastic Agents; Biotransformation; Brain Neoplasms; Child; Child, Preschool; Cycl | 1997 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child | 2000 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Bre | 2001 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition | 2002 |
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 2002 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamid | 1992 |
[Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Topics: Bone Neoplasms; Child; Cyclophosphamide; Cystitis; Female; Hematuria; Humans; Ifosfamide; Leukemia; | 1990 |